Basic Info
Website: http://www.syntapharma.com/
Stock symbol: SNTA
IPO date:2/6/07
Total shares outstanding:33.82M (5M offered at IPO)
Other reviews: Seeking Alpha
Drugs/Platforms
Drugs in trials:
STA-4783 starting Phase 3 trials for treatment of melastatic melanoma
STA-5326 in Phase 2 trials for the treatment of Rheumatoid Arthritus and CVID
Drugs in development:
STA-9090 a heat shock protein inhibitor for the treatment of cancer
STA-9584 a vascular disrupting agent for […]

Filed under: Synta Pharmaceuticals (SNTA) | Comment on this post »

Before I get into evaluating stocks, I thought I’d talk today about my strategy for investing in small/startup biotech companies.
Drugs/Platform-High Probability of Success
Well, clearly this is the most important thing to evaluate and it’s where I’ll spend most of my time (then again, I’m a scientist, so maybe I’m biased). If the drug gets […]

Filed under: Investment Strategy | 1 Comment »